Literature DB >> 3341937

Homozygous protein C deficiency in a newborn. Clinicopathologic correlation.

S Tarras1, C Gadia, L Meister, E Roldan, J B Gregorios.   

Abstract

A rare case of homozygous protein C deficiency occurred in a newborn. The patient presented with purpura fulminans in the first few hours after birth and showed multiple hemorrhagic lesions on computed tomography of the brain at 5 days of age. Neurologic symptoms developed at two weeks and the patient died at 37 weeks. His protein C level was less than 5%. Autopsy revealed thrombosis of the dural sinuses, multiple cortical infarcts, intraparenchymal hemorrhages, and hydrocephalus. The pathologic findings are correlated with the neurologic deficits and previously documented cases are reviewed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341937     DOI: 10.1001/archneur.1988.00520260102029

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Role of protein C in childhood cerebrovascular occlusive accidents.

Authors:  S Uysal; B Anlar; C Altay; S Kirazli
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

2.  Cerebral venous thrombosis in hereditary protein C deficiency.

Authors:  P Vieregge; G Schwieder; D Kömpf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosis.

Authors:  Abdulrahman Alsultan; Andrew J Gale; Kadijah Kurban; Mohammed Khalifah; Fahad B Albadr; John H Griffin
Journal:  Thromb Res       Date:  2016-04-23       Impact factor: 3.944

4.  Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension.

Authors:  C Confavreux; P Brunet; P Petiot; M Berruyer; M Trillet; G Aimard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

5.  Homozygous protein C deficiency--management with protein C concentrate.

Authors:  V Baliga; R Thwaites; M L Tillyer; A Minford; L Parapia; J Allgrove
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

6.  TAK-733 inhibits inflammatory neointimal formation by suppressing proliferation, migration, and inflammation in vitro and in vivo.

Authors:  Jun-Hee Park; Sang Woo Kim; Min-Ji Cha; Nara Yoon; Chang Youn Lee; Jiyun Lee; Hyang-Hee Seo; Sunhye Shin; Jung-Won Choi; Seahyoung Lee; Soyeon Lim; Ki-Chul Hwang
Journal:  Exp Mol Med       Date:  2018-04-20       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.